2 news items
Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress
RVMD
8 May 24
Meeting that elucidate the basis of this compound's antitumor activity and safety profile. We have also initiated exploratory clinical studies of key
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
ACB
ACORQ
ADIL
10 Apr 24
the clinical results, strong safety profile, and high compliance among patients administered AD04.
Infobird Co., Ltd
- Prev
- 1
- Next